Document is current
Any future updates will be listed below
-
Authors
Woodie, Brad R. https://orcid.org/0000-0002-7481-5216
Jones, Grace
Holovach, Phillip
Fleischer Jr, Alan B.
- License Information
-
More Information
Article History
Received: 3 January 2025
Revised: 7 February 2025
Accepted: 12 February 2025
First Online: 8 March 2025
Declarations
:
: Reviewed and approved by the IRB of the University of Cincinnati (protocol code 2021 − 1179 and date of approval: 19 April 2022).
: The IRB of the University of Cincinnati granted a waiver for patient consent because there were minimal unique patient identifiers collected in this study.
: Alan Fleischer is a consultant for Bluefin and Incyte (fees). He is an investigator for Amgen, Bayer, Biogen, CellDex, Galderma, Incyte, Leo, and UCB (research support). He is a speaker for Imedic Healthcare Solutions (Hyderabad, India). Brad Woodie, Grace Jones, and Phillip Holovach declare no conflicts of interest.
